Linalent Tablet
Marketer
Talent India
Salt Composition
Linagliptin (5mg)
Overview Linalent Tablet
DiaBeta tablets are indicated for the management of type 2 diabetes. Effective blood glucose control is achieved through combined use with a balanced diet and regular physical activity, minimizing the risk of serious diabetic complications like renal impairment and vision loss. DiaBeta is typically prescribed when dietary and exercise modifications, or other medications, prove insufficient to regulate blood sugar. Your physician may prescribe it solely or in conjunction with other antidiabetic agents. It can be administered with or without food, with dosage determined by your individual health status and glycemic readings. Adhere strictly to your doctor's prescribed regimen; discontinue use only upon their recommendation. Continued adherence to your prescribed diet and exercise program remains crucial during treatment. Lifestyle choices significantly influence diabetes management. Hypoglycemia is the most frequently reported adverse effect; familiarize yourself with its symptoms (e.g., lightheadedness, sweating, vertigo, syncope) and appropriate countermeasures (e.g., readily available glucose tablets). Nasopharyngitis may also occur. Report any persistent or concerning side effects to your physician. Prior to initiating treatment, disclose any history of kidney disease, heart conditions, or pancreatic issues. Potential drug interactions exist; inform your doctor of all medications you are currently taking. Pregnant or lactating women should seek medical counsel before commencing treatment. Limit alcohol consumption due to an increased hypoglycemia risk. Regular monitoring, including renal function and blood glucose levels, may be necessary to assess treatment efficacy.
Uses of Linalent Tablet
Managing type 2 diabetes
Major Benefits of Linalent Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Linalent Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Linalent Tablet:
- Hypoglycemia (low blood glucose level)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Cough
- Vomiting
- Diarrhea
- Constipation
How to use Linalent Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Linalent Tablets can be consumed with or without food, though consistent timing is recommended.
How Linalent Tablet works:
Linalent tablets manage diabetes by stimulating insulin secretion from the pancreas and suppressing hyperglycemic hormones. This dual action lowers both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Combining Linalent Tablet with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Data on Linalent Tablet use in pregnancy are absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Linalent Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Linalent Tablet use.
KidneySAFE IF PRESCRIBED
Linalent Tablets pose no safety concerns requiring dose modification for patients with kidney impairment. Nevertheless, individuals with end-stage renal disease (ESRD) or undergoing dialysis should use Linalent Tablets judiciously.
LiverSAFE IF PRESCRIBED
Linalent Tablets pose no safety concerns for patients with liver disease and require no dosage modification. Nevertheless, their administration is inadvisable for individuals exhibiting severe hepatic impairment.
What if you forget to take Linalent Tablet :
Should you forget a Linalent Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Linalent Tablet
| Label | Value |
|---|---|
| Chemical Type | Purine-quinazoline hybrid |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Action Class | Dipeptidyl peptidase-4 inhibitors |



